Question
Q: On 1 January 2021, Nobleman plc agreed to buy a luxury property in London for 12 million from Aristocrat plc. Contracts were exchanged in
Q: On 1 January 2021, Nobleman plc agreed to buy a luxury property in London for 12 million from Aristocrat plc. Contracts were exchanged in June 2021 and over the six-month period from the agreement to the exchange of the contracts, London's property prices had significantly risen. Belgravia plc sold an identical property for 15 million.
Nonetheless, in order to honour the gentlemen's agreement stipulated with the chief executive of Nobleman plc, the director of Aristocrat plc agreed to exchange contracts at the original price of 12 million.
The legal costs to Nobleman plc of buying the property were 120,000 and the selling costs to Aristocrat plc were 180,000.
Nobleman plc estimates that from the ownership of the property they can derive an annuity of 1 million per year for the following 30 years.
The cost of capital is expected to remain constant at 5%.
(a).
Using market prices, what is the initial 'fair value' of the property to be recorded in the financial statements of Nobleman plc?
Group of answer choices
120,000
15,180,000
12,000,000il
15,000,000
Using entity specific prices, what is the initial 'net realisable value' of the property for Nobleman plc?
12,000,000
15,370,000
14,820,000
15,120,000
Using entity specific prices, what is the initial 'replacement cost' of the property for Nobleman plc?
12,120,000
12,000,000
15,120,000
15,370,000
Using entity specific prices, what is the initial 'value in use' of the property for Nobleman plc?
14,820,000
12,000,000
15,370,000
15,000,000
Using entity specific prices, what is the initial 'recoverable amount' of the property for Nobleman plc?
15,120,000
nil
15,370,000
12,120,000
Using entity specific prices, what is the initial 'deprival value' of the property for Nobleman plc?
12,000,000
15,370,000
14,820,000
15,120,000
Using entity specific prices, what is the initial 'historical cost' of the property for Nobleman plc?
15,000,000
14,820,000
15,370,000
12,120,000
(b)
Paradox plc, a company operating within the pharmaceuticals sector, is reviewing the fair value of certain assets in accordance with IFRS 13 Fair Value Measurement.
The company carries an asset that is traded in different markets and is uncertain as to which valuation it should use. Under IFRS, the asset has to be valued at fair value. Paradox plc currently buys and sells the assets in the Asian market. The data in relation to the asset is set out below:
Year to 31 December 2020 | American market | European market | Asian market |
Volume of market - units | 16 million | 8 million | 4 million |
Price | 76 | 64 | 88 |
Cost of entering the market | 8 | 8 | 12 |
Transaction costs | 4 | 8 | 8 |
In accordance with IFRS 13 Fair Value Measurement, what is the 'principal market' for the asset?
Group of answer choices
American market
Asian market
European market
American and European markets
In accordance with IFRS 13 Fair Value Measurement, what is the 'most advantageous market' for the asset?
Group of answer choices
American and European marketsnil
Asian market
European market
American market
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started